Suppr超能文献

作为炎症介质的血液凝固因子。

Blood coagulation factors as inflammatory mediators.

作者信息

Schoenmakers Saskia H H F, Reitsma Pieter H, Spek C Arnold

机构信息

Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Blood Cells Mol Dis. 2005 Jan-Feb;34(1):30-7. doi: 10.1016/j.bcmd.2004.09.001.

Abstract

After the first observations about blood coagulation by Hippocrates, it took until the early 1900s before the classic theory of blood coagulation was presented. As more and more other coagulation factors were discovered, the four-factor coagulation scheme became more complex, but better understood, leading to the current coagulation cascade. As during the last decade it turned out that coagulation factors might do more than just promoting (or inhibiting) blood coagulation, new scientific avenues were pursued focusing on coagulation-independent properties of individual coagulation factors. This led to the current understanding that coagulation factors, like tissue factor (TF), FVII, FX, and thrombin, are important players in inflammation, vascular development, angiogenesis, and tumorigenesis. However, the molecular mechanism by which coagulation factors exert their pleiotropic effects in pathophysiology remains one of the major challenges in the field. This overview presents current insight in how the main coagulation factors might induce inflammation.

摘要

在希波克拉底首次观察到血液凝固现象之后,直到20世纪初才提出经典的血液凝固理论。随着越来越多的其他凝血因子被发现,四因子凝血方案变得更加复杂,但也得到了更好的理解,从而形成了当前的凝血级联反应。在过去十年中,人们发现凝血因子可能不仅仅起到促进(或抑制)血液凝固的作用,于是开始探索新的科学途径,聚焦于单个凝血因子的非凝血相关特性。这使得人们目前认识到,凝血因子,如组织因子(TF)、FVII、FX和凝血酶,在炎症、血管发育、血管生成和肿瘤发生过程中起着重要作用。然而,凝血因子在病理生理学中发挥其多效性作用的分子机制仍然是该领域的主要挑战之一。本综述介绍了目前对于主要凝血因子如何诱导炎症的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验